These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16807754)

  • 1. Influence of anatomy and head position on intranasal drug deposition.
    Merkus P; Ebbens FA; Muller B; Fokkens WJ
    Eur Arch Otorhinolaryngol; 2006 Sep; 263(9):827-32. PubMed ID: 16807754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deposition of intranasal glucocorticoids--preliminary study.
    Rapiejko P; Sosnowski TR; Sova J; Jurkiewicz D
    Otolaryngol Pol; 2015; 69(6):30-8. PubMed ID: 26860605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy of nasal drop and nasal spray applications of fluticasone propionate in nasal polyps.
    Demirel T; Orhan KS; Keleş N; Değer K
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(1):1-6. PubMed ID: 18443395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT assessment of the effect of fluticasone propionate aqueous nasal spray treatment on lower turbinate hypertrophy due to vasomotor rhinitis.
    Arikan OK; Koc C; Kendi T; Muluk NB; Ekici A
    Acta Otolaryngol; 2006 Jan; 126(1):37-42. PubMed ID: 16308253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 'best method' of topical nasal drug delivery: comparison of seven techniques.
    Merkus P; Ebbens FA; Muller B; Fokkens WJ
    Rhinology; 2006 Jun; 44(2):102-7. PubMed ID: 16792167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate.
    Molet SM; Hamid QA; Hamilos DL
    Laryngoscope; 2003 Oct; 113(10):1803-12. PubMed ID: 14520110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
    Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
    Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical issues relating to intranasal steroid therapy.
    Tan LK
    Singapore Med J; 2002 Aug; 43(8):412-4. PubMed ID: 12507027
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of Fluticasone Furoate on Clinical and Immunological Outcomes (IL-17) for Patients With Nasal Polyposis Naive to Steroid Treatment.
    Venkatesan N; Lavigne P; Lavigne F; Hamid Q
    Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):213-8. PubMed ID: 26405064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of intranasal cortocosteroidson on the expression of Aquaporin-5 in human nasal polyps].
    Li Z; Gao Q; Zhen H; Cui Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Nov; 18(11):647-9. PubMed ID: 15715403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of chemical cautery (AgNo3) and steroid spray against SMD (submucosal diathermy) in the treatment of symptomatic inferior turbinate hypertrophy (ITH).
    Kafle P; Maharjan M; Shrestha S; Toran KC
    Kathmandu Univ Med J (KUMJ); 2007; 5(3):335-9. PubMed ID: 18604050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery.
    Aukema AA; Mulder PG; Fokkens WJ
    J Allergy Clin Immunol; 2005 May; 115(5):1017-23. PubMed ID: 15867860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the best head position for instillation of steroid nose drops.
    Kayarkar R; Clifton NJ; Woolford TJ
    Clin Otolaryngol Allied Sci; 2002 Feb; 27(1):18-21. PubMed ID: 11903366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa.
    Hallén H; Enerdal J; Graf P
    Clin Exp Allergy; 1997 May; 27(5):552-8. PubMed ID: 9179430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intranasal steroid therapy in inflammatory nasal-sinus pathology in pediatric age].
    Berlucchi M; Tomenzoli D
    Minerva Pediatr; 2009 Jun; 61(3):323-31. PubMed ID: 19461575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind comparison of intranasal fluticasone propionate, 200 micrograms, once daily with 200 micrograms twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweed.
    Dolovich J; O'Connor M; Stepner N; Smith A; Sharma RK
    Ann Allergy; 1994 May; 72(5):435-40. PubMed ID: 8179230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections after endoscopic polypectomy using nasal steroids.
    Bross-Soriano D; Arrieta-Gómez JR; Prado-Calleros H
    Otolaryngol Head Neck Surg; 2004 Mar; 130(3):319-22. PubMed ID: 15054373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery.
    Neubauer PD; Schwam ZG; Manes RP
    Int Forum Allergy Rhinol; 2016 Mar; 6(3):233-7. PubMed ID: 26679480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of therapeutic effect of fluticasone propionate aqueous nasal spray.
    Meltzer EO; Rickard KA; Westlund RE; Cook CK
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):286-91. PubMed ID: 11289326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Videoendoscopic analysis of nasal steroid distribution.
    Weber R; Keerl R; Radziwill R; Schick B; Jaspersen D; Dshambazov K; Mlynski G; Draf W
    Rhinology; 1999 Jun; 37(2):69-73. PubMed ID: 10416252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.